The global hemostasis products market is expected to exceed US$ 7 billion by 2024, registering a compound annual growth rate (CAGR) of more than 4% during the forecast period. The increase in many surgical and trauma cases and extensive research and technological advancements are expected to drive the market. However, the rising use of the off-label product and patent loss and stringent regulatory policies are hampering the growth of the market.
In this report, the global hemostasis products market is segmented by product, application, end users, and region. On the basis ofproduct, the market is segmented into advanced hemostasis, infusible hemostasis, and topical hemostasis. The infusible hemostasis segment accounted for the largest share of 47% of the market in 2015. The advanced hemostasis segment is divided into synthetic sealants, fibrin, thrombin, and flowable. The infusible hemostasis segmentincludes prothrombin complex, fresh frozen plasma, FVIII derived from blood, and platelet concentrates from donor blood. The topical hemostasis segmentis divided into collagen, oxidized regenerated cellulose, polysaccharide, and gelatin. The market by application includes thrombosis, stroke, trauma, surgery, hemophilia, and myocardial infarction. On the basis ofend user, the market is segmented into hospitals and clinics.
The global hemostasis products market is segmentedon the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America is the largest hemostasis products market. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional hemostasis products market and analyzes the variations in the growth of the industry in certain regions.
Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc., CSL Behring LLC, Grifols, S.A., HemCon Medical Technologies, Inc., Integra LifeSciences Corporation, Johnson & Johnson, Medtronic Plc, and Pfizer, Inc. are the most active players in the hemostasis products market.
A glimpse of the report structure is provided in the report description available on the website.
This report covers the hemostasis products market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the hemostasis products market will help customers with the identification of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org